Pt Kalbe Farma Tbk.
(OTC) PTKFY
Pt Kalbe Farma Tbk. Financials at a Glance
Market Cap
$1.94B
Revenue (TTM)
IDR 36.34T
Net Income (TTM)
IDR 3.64T
EPS (TTM)
$0.96
P/E Ratio
8.92
Dividend
$0.22
Beta (Volatility)
0.21 (Low)
Dividend
$0.22
Beta (Volatility)
0.21 (Low)
Price
$8.35
Volume
9
Open
$8.35
Price
$8.35
Volume
9
Open
$8.35
Previous Close
$8.35
Daily Range
$8.35 - $8.35
52-Week Range
$8.35 - $19.50
Estimated Earnings Date
Apr 28, 2026
Dividend
$0.22
Beta (Volatility)
0.21 (Low)
Price
$8.35
Volume
9
Open
$8.35
Previous Close
$8.35
Daily Range
$8.35 - $8.35
52-Week Range
$8.35 - $19.50
Estimated Earnings Date
Apr 28, 2026
PTKFY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pt Kalbe Farma Tbk.
Industry
Pharmaceuticals
Sector
Health CareEmployees
12,895
CEO
Bernadette Ruth Setiady
Website
www.kalbe.co.idHeadquarters
Jakarta, 10510, ID
PTKFY Financials
Key Financial Metrics (TTM)
Gross Margin
39%
Operating Margin
12%
Net Income Margin
10%
Return on Equity
15%
Return on Capital
17%
Return on Assets
11%
Earnings Yield
11.21%
Dividend Yield
2.61%
Payout Ratio
45.22%
Stock Overview
Market Cap
$1.94B
Shares Outstanding
226.24M
Volume
9
Avg. Volume
142.156
Financials (TTM)
Gross Profit
IDR 14.06T
Operating Income
IDR 4.55T
EBITDA
IDR 5.18T
Operating Cash Flow
IDR 3.27T
Capital Expenditure
-IDR 809.87B
Free Cash Flow
IDR 2.46T
Cash & ST Invst.
IDR 4.49T
Total Debt
IDR 297.28B
Pt Kalbe Farma Tbk. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
IDR 9.82T
+11.0%
Gross Profit
IDR 3.66T
-0.5%
Gross Margin
37.24%
N/A
Market Cap
$1.94B
N/A
Market Cap/Employee
$151.10K
N/A
Employees
12,841
N/A
Net Income
IDR 1.04T
-3.0%
EBITDA
IDR 1.53T
+0.1%
Quarterly Fundamentals
Total Cash
IDR 4.53T
-3.4%
Total Debt
IDR 304.45B
-42.7%
Accounts Receivable
IDR 6.59T
+6.0%
Inventory
IDR 7.39T
+12.6%
Long Term Debt
IDR 171.28B
-22.4%
Short Term Debt
IDR 133.17B
-57.2%
Return on Assets
11.31%
N/A
Return on Invested Capital
16.86%
N/A
Free Cash Flow
IDR 127.03B
-31.7%
Operating Cash Flow
IDR 286.28B
-16.9%